The increasing ability to harness cannabidiol, a derivative of cannabis, to treat medical problems is due to the body’s endocannabinoid system (ECS). This system, discovered by scientists at the Hebrew University of Jerusalem, is a set of natural pathways in our brain and body which carry messages to various regions to manage and regulate pain, appetite, mood regulation, and memory.
Israel Cancer Research Fund approved grants to the Hebrew University, and other Israeli institutions, for studies in blood, brain, breast, colorectal and many other types of cancers. Prof. Yinon Ben-Neriah, of Hebrew University’s Faculty of Medicine, and 2019 EMET laureate, will be able to pursue further groundbreaking work on chronic myelogenous leukemia, due to this grant.
Porsche, the luxury car company, has decided to invest $2 million in the Israeli startup TriEye. TriEye is a company that uses SWIR (short-wave-infrared) technology to allow autonomous vehicles to operate effectively even under challenging weather conditions. The technology was developed in the Hebrew University’s Center for Nanoscience and Nanotechnology.
The Glocal MA program at The Hebrew University is helping making a difference on the ground. Together with organizations like Tevel b’Tzedek, HU international students and young Israeli backpackers work in impoverished villages across South-East Asia to improve their residents’ nutrition, provide clean water, and create basic decent human living conditions for housing, health and education.
OrCam start-up, which was established by Mobileye’s founders Amnon Shashua and Ziv Aviram, has developed devices that assist the blind and visually impaired with a camera and smart algorithms. Mobileye was based on Hebrew University technology.
“AACSB International has awarded its accreditation to The Jerusalem School of Business Administration at The Hebrew University of Jerusalem. The AACSB is the longest-serving global accrediting body for business schools, and the largest business education network connecting students, educators, and businesses worldwide.
Ted-Style Talks by Keynote Hebrew University Speakers on “High-Tech Jerusalem” This year’s Board of Governors highlighted High-Tech Jerusalem. While outdoor ceremonies, musical events and a fun-filled culinary evening in Jerusalem’s Mahane Yehuda emphasized the centrality of Jerusalem in the University’s identity, our HUJI Talks showcased the increasing importance of High-Tech in every facet of our research as well as in our daily lives.
Eliezer Rabinovici, professor of Particle Physics at The Hebrew University of Jerusalem, recently received the 2019 Award for Science Diplomacy from the American Association for the Advancement of Science (AAAS) for his outstanding scientific and diplomatic contributions to SESAME (Synchrotron-light Experimental Science and Applications in the Middle East), founded in Jordan in 2017.
Professor Rotem Karni, of Hebrew University’s Institute for Medical Research-Israel-Canada, has designed a molecule that inhibits brain (glioblastoma) tumor growth by regulating the tumor-produced proteins. Glioblastoma is a serious and incurable brain cancer. Until now, a patient diagnosed with glioblastoma typically has 11-20 months to live, and cells affected by this cancer quickly become resistant to chemotherapy treatment.
EMET Prize-winning scientist, Professor Daniel Rosenfeld, of Hebrew University of Jerusalem’s Herrmann Institute of Earth Sciences, has developed a satellite imaging method which has determined that the extent of global warming has been grossly underestimated.